Literature DB >> 2903552

Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys.

D E Redmond1, F Naftolin, T J Collier, C Leranth, R J Robbins, C D Sladek, R H Roth, J R Sladek.   

Abstract

Studies in animals suggest that fetal neural grafts might restore lost neurological function in Parkinson's disease. In monkeys, such grafts survive for many months and reverse signs of parkinsonism, without attendant graft rejection. The successful and reliable application of a similar transplantation procedure to human patients, however, will require neural tissue obtained from human fetal cadavers, with demonstrated cellular identity, viability, and biological safety. In this report, human fetal neural tissue was successfully grafted into the brains of monkeys. Neural tissue was collected from human fetal cadavers after 9 to 12 weeks of gestation and cryopreserved in liquid nitrogen. Viability after up to 2 months of storage was demonstrated by cell culture and by transplantation into monkeys. Cryopreservation and storage of human fetal neural tissue would allow formation of a tissue bank. The stored cells could then be specifically tested to assure their cellular identity, viability, and bacteriological and virological safety before clinical use. The capacity to collect and maintain viable human fetal neural tissue would also facilitate research efforts to understand the development and function of the human brain and provide opportunities to study neurological diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903552     DOI: 10.1126/science.2903552

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease.

Authors:  H Sauer; E M Frodl; A Kupsch; G ten Bruggencate; W H Oertel
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

3.  Large animal models are critical for rationally advancing regenerative therapies.

Authors:  Dustin R Wakeman; Andrew M Crain; Evan Y Snyder
Journal:  Regen Med       Date:  2006-07       Impact factor: 3.806

Review 4.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

Review 5.  Microfluidics for cryopreservation.

Authors:  Gang Zhao; Jianping Fu
Journal:  Biotechnol Adv       Date:  2017-01-30       Impact factor: 14.227

6.  Autotransplantation of superior cervical ganglion to the caudate nucleus in three patients with Parkinson's disease (preliminary report).

Authors:  M Horvath; E Pasztor; M Palkovits; A Solyom; M Tarczy; N Lekka; E Csanda
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

Review 7.  Cellular repair in the parkinsonian nonhuman primate brain.

Authors:  Donald Eugene Redmond; Stephanie Weiss; John D Elsworth; Robert H Roth; Dustin R Wakeman; Kimberly B Bjugstad; Timothy J Collier; Barbara C Blanchard; Yang D Teng; Evan Y Synder; John R Sladek
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

8.  Cryopreservation and culture of the human fetal brain tissues.

Authors:  R S Cai; D L Xue; X H Jiang
Journal:  J Tongji Med Univ       Date:  1993

Review 9.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 10.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.